Actelis Networks Secures $30M Equity Line, Faces Dilution Risk

TL;DR

**ASNS is tapping an equity line for up to $30M, but expect massive dilution as White Lion unloads millions of shares, likely crushing the stock price.**

AI Summary

Actelis Networks, Inc. (ASNS) filed an S-1/A on November 4, 2025, detailing an equity line of credit (ELOC) and a private placement (PIPE) with White Lion Capital, LLC. The company may issue up to 14,711,737 shares of common stock to White Lion, including 10,000,000 shares under the ELOC, 1,200,000 commitment shares (valued at $0.625 per share on October 3, 2025), 871,766 shares from the PIPE, and 2,639,971 shares from Pre-Funded Warrants. Actelis will not receive proceeds from White Lion's resale of these shares but may receive up to $30.0 million in aggregate gross proceeds from direct sales to White Lion under the ELOC. The company's common stock closed at $0.50 per share on November 3, 2025, on the Nasdaq Capital Market. A proposed reverse stock split at a ratio of 1-for-7 to 1-for-12 is scheduled for a shareholder vote on November 7, 2025, which could significantly impact the share count and price.

Why It Matters

This S-1/A filing reveals Actelis Networks' strategy to raise capital through an equity line of credit and private placement, potentially injecting up to $30.0 million into the company. However, the issuance of up to 14,711,737 shares to White Lion Capital poses a significant dilution risk for existing investors, which could depress the stock price, especially given the current $0.50 share price. For employees, this capital infusion could provide operational stability, while customers might see continued product development in cyber-hardened IoT solutions. In the competitive landscape of hybrid fiber networking, this funding is crucial for Actelis to maintain its market position and invest in its patented technology, but the method of financing introduces substantial market uncertainty.

Risk Assessment

Risk Level: high — The risk level is high due to the potential for significant dilution from the issuance of up to 14,711,737 shares of common stock to White Lion Capital, LLC. The filing explicitly states, "Sales of a substantial number of our shares of Common Stock in the public market by the selling stockholder... could increase the volatility of and cause a significant decline in the market price of our securities." Furthermore, the company's common stock closed at $0.50 per share on November 3, 2025, indicating a low valuation susceptible to further downward pressure.

Analyst Insight

Investors should exercise extreme caution and consider the high dilution risk before investing in ASNS. Given the potential for White Lion to sell millions of shares into the market, current shareholders might consider reducing their exposure, while prospective investors should wait for clarity on the actual number of shares issued and the impact of the proposed reverse stock split.

Financial Highlights

debt To Equity

0.1

revenue

$1.4 million

operating Margin

-721.4%

total Assets

$10.1 million

total Debt

$0.1 million

net Income

-$10.1 million

eps

-$1.08

gross Margin

21.4%

cash Position

$1.1 million

revenue Growth

-28.0%

Key Numbers

• 14,711,737 — Maximum shares of Common Stock (Shares White Lion Capital, LLC may offer and sell from time to time)
• $30.0 million — Maximum gross proceeds (Amount Actelis Networks, Inc. may receive from White Lion under the ELOC Purchase Agreement)
• 10,000,000 — Shares under ELOC (Shares Actelis may elect to issue and sell to White Lion under the ELOC Purchase Agreement)
• 1,200,000 — Commitment shares (Shares issuable to White Lion as commitment shares under the ELOC Purchase Agreement)
• 871,766 — PIPE shares (Shares issued to White Lion pursuant to the PIPE Purchase Agreement)
• 2,639,971 — Pre-Funded Warrant shares (Shares issuable to White Lion upon exercise of Pre-Funded Warrants from the PIPE Purchase Agreement)
• $0.50 — Closing stock price (Closing price of ASNS Common Stock on Nasdaq Capital Market on November 3, 2025)
• 1-for-7 to 1-for-12 — Proposed reverse stock split ratio (Range for the reverse share split to be voted on November 7, 2025)

Key Players & Entities

• Actelis Networks, Inc. (company) — Registrant and issuer of securities
• White Lion Capital, LLC (company) — Selling Stockholder and counterparty to ELOC and PIPE agreements
• Tuvia Barlev (person) — Chief Executive Officer and Chairman of the Board of Directors for Actelis Networks, Inc.
• Eyal Peled, Esq. (person) — Legal counsel from Greenberg Traurig LLP for Actelis Networks, Inc.
• Nasdaq Capital Market (regulator) — Stock exchange where ASNS Common Stock is traded
• United States Securities and Exchange Commission (regulator) — Regulatory body for the S-1/A filing
• $30.0 million (dollar_amount) — Maximum aggregate gross proceeds Actelis may receive from White Lion under the ELOC Purchase Agreement
• $0.625 (dollar_amount) — Closing price per share of ASNS Common Stock on Nasdaq Capital Market on October 3, 2025, used for commitment shares valuation
• $0.50 (dollar_amount) — Closing price per share of ASNS Common Stock on Nasdaq Capital Market on November 3, 2025
• November 7, 2025 (date) — Date of the extraordinary general meeting of shareholders to vote on a reverse share split

FAQ

Risk Factors

• Reliance on Equity Financing [high — financial]: The company's ability to raise capital through the ELOC and PIPE with White Lion Capital is critical for its ongoing operations and future growth. There is a risk that the company may not be able to draw down the full $30.0 million under the ELOC, or that future financing rounds may be difficult to secure on favorable terms, potentially impacting its ability to fund its business plan.
• Reverse Stock Split Impact [medium — market]: The proposed reverse stock split, ranging from 1-for-7 to 1-for-12, is intended to increase the per-share market price of the common stock to meet Nasdaq listing requirements. However, reverse splits can be perceived negatively by investors and may not guarantee sustained compliance with listing rules if the underlying business performance does not improve.
• Execution of Business Strategy [medium — operational]: Actelis Networks' success depends on its ability to execute its business strategy, which includes developing and marketing its products and services. Failure to effectively manage operations, innovate, or gain market traction could lead to a decline in revenue and profitability.
• Nasdaq Listing Compliance [high — regulatory]: The company is seeking to regain compliance with Nasdaq's minimum bid price requirement. Failure to maintain compliance, even after a potential reverse stock split, could result in delisting from the Nasdaq Capital Market, significantly reducing liquidity and investor confidence.
• Dilution from Share Issuances [high — financial]: The issuance of up to 14,711,737 shares to White Lion Capital, including shares under the ELOC, commitment shares, PIPE shares, and pre-funded warrants, represents a significant potential dilution to existing shareholders. This dilution could negatively impact the value of their holdings.

Industry Context

Actelis Networks operates in the telecommunications equipment sector, providing solutions for network connectivity and management. The industry is characterized by rapid technological advancements, intense competition, and a constant need for infrastructure upgrades. Companies in this space often face challenges related to product development cycles, supply chain management, and securing capital for expansion.

Regulatory Implications

The company's primary regulatory concern is maintaining its listing on the Nasdaq Capital Market. The proposed reverse stock split is a direct response to the minimum bid price requirement. Failure to comply could lead to delisting, impacting liquidity and investor access.

What Investors Should Do

1. Monitor the outcome of the reverse stock split vote.
2. Analyze the terms and execution of the ELOC and PIPE.
3. Evaluate the company's operational performance and revenue trends.

Key Dates

• 2025-11-04: Filing of S-1/A — Details the equity line of credit and private placement with White Lion Capital, outlining potential share issuances and capital raises.
• 2025-11-07: Shareholder Vote on Reverse Stock Split — Crucial for potential compliance with Nasdaq's minimum bid price requirement and impacts share structure.
• 2025-11-03: Closing Stock Price — The stock closed at $0.50, highlighting the need for a reverse stock split to meet Nasdaq listing standards.

Glossary

Equity Line of Credit (ELOC)

An agreement where a company can sell shares of its stock to an investor at its discretion over a period of time, up to a certain limit, at prevailing market prices or pre-determined prices. (Actelis has an ELOC with White Lion Capital, allowing it to potentially raise up to $30.0 million by issuing shares.)

Private Investment in Public Equity (PIPE)

A private placement of securities by a publicly traded company to institutional investors or accredited investors. (Actelis is conducting a PIPE with White Lion Capital, involving the sale of 871,766 shares and pre-funded warrants.)

Pre-Funded Warrants

Warrants that allow the holder to purchase shares at a nominal exercise price, effectively representing immediate ownership of the underlying shares without the full upfront cost of purchasing them directly. (These are part of the PIPE and represent 2,639,971 shares issuable upon exercise, indicating a commitment to acquire a significant stake.)

Commitment Shares

Shares issued to an investor as compensation or incentive for entering into a financing agreement, such as an ELOC. (White Lion Capital is receiving 1,200,000 commitment shares, valued at $0.625 each on October 3, 2025, as part of the ELOC agreement.)

Reverse Stock Split

A corporate action where a company reduces the number of its outstanding shares by consolidating them into fewer, proportionally more valuable shares. (Actelis is proposing a reverse stock split to increase its share price and comply with Nasdaq listing rules.)

Year-Over-Year Comparison

The S-1/A filing indicates a continued need for significant capital infusion, as evidenced by the ELOC and PIPE with White Lion Capital. Revenue has declined by 28.0% year-over-year, and net losses have widened, suggesting ongoing operational challenges. The company's cash position has decreased, underscoring the urgency of the financing arrangements and the proposed reverse stock split to address Nasdaq listing requirements.

Key Financial Figures

• $0.0001 — o; or “Actelis”), par value $0.0001 per share (the “Common Stock&rdqu
• $0.625 — Purchase Agreement (assuming a value of $0.625 per share, the closing price of our sha
• $30.0 million — o this prospectus. We may receive up to $30.0 million in aggregate gross proceeds from White
• $0.50 — Stock on the Nasdaq Capital Market was $0.50 per share. Investing in our securitie
• $0.615 — f Common Stock, for a purchase price of $0.615 per share and related Common Warrants,
• $1 million — gregate gross proceeds of approximately $1 million. The July 2025 Private Placement closed
• $35,000 — also agreed to pay the Placement Agent $35,000 for non-accountable expenses and a mana
• $0.7688 — tock) at an exercise price per share of $0.7688 which will be exercisable commencing on
• $2,50 — to our failure to maintain a minimum of $2,50

Filing Documents

• ea0263631-s1a2_actelis.htm (S-1/A) — 294KB
• ea026363101ex5-1_actelis.htm (EX-5.1) — 9KB
• ea026363101ex23-1_actelis.htm (EX-23.1) — 2KB
• image_001.jpg (GRAPHIC) — 13KB
• ex5-1_001.jpg (GRAPHIC) — 8KB
• image_002.jpg (GRAPHIC) — 2KB
• 0001213900-25-106151.txt ( ) — 338KB

Use of Proceeds

Use of Proceeds 9 White Lion Transaction 10 Selling Stockholder 12 Description of Offered Securities 13 Plan of Distribution 18 Legal Matters 19 Experts 19 Where You Can Find More Information 19 Incorporation of Certain Information by Reference 20 i ABOUT THIS PROSPECTUS Unless the context indicates otherwise, references in this prospectus to “Actelis,” “we,” “us,” “our,” “the Company,” “our company” and similar terms refer to Actelis Networks, Inc., a Delaware corporation. Actelis has a wholly-owned subsidiary, Actelis Networks Israel, Ltd, an Israeli company. This prospectus is part of a registration statement that we filed with the Securities and Exchange Commission (the “SEC”). The selling stockholder named in this prospectus may from time to time sell the securities described in the prospectus. You should read this prospectus together with the more detailed information regarding our company, our Common stock, and our financial statements and notes to those statements that appear elsewhere in this prospectus and any applicable prospectus supplement together with the additional information that we incorporate in this prospectus by reference, which we describe under the heading “Where You Can Find More Information.” You should rely only on the information contained in, or incorporated by reference in, this prospectus and in any accompanying prospectus supplement. We have not authorized anyone to provide you with different information from that contained in, or incorporated by reference in, this prospectus. You should not assume that the information in this prospectus or any prospectus supplement is accurate as of any date other than the date on the front of those documents or that any document incorporated by reference is accurate as of any date other than its filing date. You should not consider this prospectus to be an offer or

Forward-looking statements

Forward-looking statements are based on our management’s current expectations, estimates, forecasts and projections about our business and the industry in which we operate and our management’s beliefs and assumptions, and are not guarantees of future performance or development and involve known and unknown risks, uncertainties and other factors that are in some cases beyond our control. As a result, any or all of our forward-looking include, among other things, those listed under “Risk Factors,” “Use of Discussion and Analysis of Financial Condition and Results of Operations,” “Business” and elsewhere herein or by incorporation by reference. Potential investors are urged to consider these factors carefully in evaluating the forward-looking statements. You should read thoroughly this prospectus and the documents that we refer to with the understanding that our actual future results may be materially different from and worse than what we expect. We qualify all of our forward-looking statements by these cautionary statements. The forward-looking statements included in this prospectus speak only as of the date of this prospectus. Although we believe that the expectations reflected in the forward-looking in the forward-looking statements will be achieved or will occur. Except as required by law, we assume no obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future. You should, however, review the factors and risks we describe in the reports we will file from time to time with the SEC after the date of this prospectus. See “Where You Can Find More Information.&rd

View Full Filing

View this S-1/A filing on SEC EDGAR